11:46 AM EST - Lorus Therapeutics Inc. : reported a third quarter net loss of $2.5 million or $0.01 per share, compared to a net loss of $3.9 million or $0.02 per share in the previous-year quarter. Revenue for the quarter was $64,000, up from $3,000 in the last-year quarter. Lorus Therapeutics Inc.
shares T.LOR are trading $0.005 at $0.05.
